Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026)
Artiva Biotherapeutics' Interest & Investment Income was $1.89 million in Q2 2026, up 20.8% from $1.56 million a year earlier and up 106.8% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Interest & Investment Income (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Artiva Biotherapeutics' Interest & Investment Income was $5.33 million through Jun 30, 2026, down 28.4% year-over-year; for FY2025, it was $5.96 million, up 11.4% from FY2024.
- In earlier years, Interest & Investment Income was $5.35 million in FY2024 (+111.0%) and $2.54 million in FY2023.
- The Q2 2026 figure marks the highest quarterly Interest & Investment Income since Q4 2024.
- Compared with a year earlier, Interest & Investment Income was higher in five of the last eight quarters, with growth averaging 103.8%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2024 (growth of 341.6%); the worst was Q1 2026 (a decline of 51.1%).
- Per Business Quant data, ARTV's Interest & Investment Income in the three quarters before Q2 2026 was $912,000 (Q1 2026), $1.16 million (Q4 2025) and $1.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Artiva Biotherapeutics | 200.70 Mn | -118.40 Mn | - | 3.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.14 Mn |
| Jun 30, 2026 | 1.89 Mn |
| Mar 31, 2026 | 912,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 676,000.00 |
| Mar 31, 2024 | 650,000.00 |
| Dec 31, 2023 | 583,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 509,000.00 |
API Access
Artiva Biotherapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();